Rxsight Inc (RXST) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Rxsight Inc   (NASDAQ: RXST)
 

Rxsight Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Rxsight Inc 's inventory turnover ratio sequentially decreased to 0.82 in the third quarter 2026, unsurprisingly, as the Rxsight Inc markets continue to deteriorate, and RXST's faces growing challenges to bring down its inventories. Rxsight Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 445 days, from 420 days, in the Jun 30 2026 quarter.

Within Healthcare sector 331 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1273 in the second quarter 2026, to 1851.

RXST Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Rxsight Inc Market Share?

What is Inventory Turnover Ratio?




RXST Inventory Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 36.76 % 48.11 % 47.91 % 43.39 % 33.58 %
Y / Y Cost of Sales Growth 8.12 % -1.81 % -22.22 % -33.33 % -40 %
Inventory Turnover Ratio (TTM) 0.82 0.87 0.96 1.14 1.41
RXST's Total Ranking # 1851 # 1273 # 1292 # 1090 #
Average inventory processing period 445 419 379 321 260
Seq. Inventory Growth 6.67 % 6.45 % 10.49 % 9.01 % 15.52 %
Seq. Cost of Sales Growth -17.42 % 12.21 % -12.5 % 33.33 % -25 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 147
Healthcare Sector # 332
Overall Market # 1851

Inventory Turnover Ratio Statistics
High Average Low
2.42 1.79 0.82
(Mar 31 2022)   (Sep 30 2026)




Financial Statements
Rxsight Inc 's Inventories $ 40 Millions Visit RXST's Balance sheet
Rxsight Inc 's Cost of Revenues TTM $ 29 Millions Visit RXST's Income Statement
What are RXST's Sales? Visit RXST's Sales by Segment

Other Inventory Turnover Ratios
Rxsight Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RXST's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RXST's Competitors
Inventory Turnover Ratio for RXST's Suppliers
Inventory Turnover Ratio for RXST's Customers

You may also want to know
RXST's Sales Growth Rates RXST's Pe Price to earnings ratio RXST's Receivables Turnover Ratio RXST's Stock Quote
RXST's Net Income Growth Rates RXST's Ps Price to Sales ratio RXST's Sales per Employee RXST's Asset Turnover Ratio
RXST's Net Margin RXST's Pb Price to Book ratio RXST's Financial Strength Ratios RXST's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  2.03 $ 16.819  Millions$ 8  Millions
Bausch and Lomb Corp  2.01 $ 1,986.000  Millions$ 990  Millions
Clearpoint Neuro Inc   1.98 $ 17.564  Millions$ 9  Millions
Alpha Pro Tech Ltd   1.97 $ 40.363  Millions$ 21  Millions
Intuitive Surgical Inc   1.91 $ 3,799.300  Millions$ 1,986  Millions
Indivior Pharmaceuticals Inc   1.88 $ 208.000  Millions$ 111  Millions
Tenet Healthcare Corp  1.88 $ 642.000  Millions$ 342  Millions
Trisalus Life Sciences Inc   1.86 $ 7.291  Millions$ 4  Millions
Elutia Inc   1.84 $ 3.772  Millions$ 2  Millions
Amgen Inc   1.81 $ 11,319.000  Millions$ 6,255  Millions
Haemonetics Corporation  1.80 $ 558.423  Millions$ 310  Millions
Orthofix Medical Inc   1.78 $ 244.423  Millions$ 137  Millions
Iradimed Corporation  1.78 $ 21.878  Millions$ 12  Millions
Harvard Bioscience Inc   1.76 $ 38.986  Millions$ 22  Millions
Ceribell Inc   1.74 $ 12.160  Millions$ 7  Millions
Axsome Therapeutics Inc   1.67 $ 58.422  Millions$ 35  Millions
Ocular Therapeutix Inc   1.66 $ 6.389  Millions$ 4  Millions
Insmed Inc  1.66 $ 237.067  Millions$ 143  Millions
Stryker Corp  1.66 $ 9,116.000  Millions$ 5,499  Millions
Bruker Corporation  1.66 $ 1,838.200  Millions$ 1,110  Millions
Bio rad Laboratories Inc   1.64 $ 1,264.000  Millions$ 769  Millions
Pfizer Inc  1.64 $ 16,940.000  Millions$ 10,322  Millions
Integra Lifesciences Holdings Corp  1.62 $ 789.329  Millions$ 486  Millions
Conmed Corporation  1.61 $ 580.951  Millions$ 361  Millions
Sanuwave Health Inc   1.54 $ 9.845  Millions$ 6  Millions
Humacyte Inc   1.53 $ 13.780  Millions$ 9  Millions
Waters Corporation  1.51 $ 1,797.864  Millions$ 1,192  Millions
Axogen inc   1.49 $ 68.923  Millions$ 46  Millions
Aurinia Pharmaceuticals Inc   1.29 $ 30.165  Millions$ 23  Millions
Hyperfine Inc   1.28 $ 8.502  Millions$ 7  Millions

Date modified: 2026-11-04T15:25:11+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.